Australian Clinical Labs
ACL.AX
#7759
Rank
โ‚น41.32 B
Marketcap
โ‚น221.54
Share price
0.60%
Change (1 day)
41.85%
Change (1 year)

Revenue for Australian Clinical Labs (ACL.AX)

Revenue in 2026: โ‚น47.52 Billion

According to Australian Clinical Labs's latest financial reports the company's current revenue (TTM ) is โ‚น47.52 Billion. In 2026 the company made a revenue of โ‚น47.52 Billion an increase over the revenue in the year 2025 that were of โ‚น45.63 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Australian Clinical Labs from 2021 to 2026

Annual revenue

Year Revenue Change
2026โ‚น47.52 B4.15%
2025โ‚น45.63 B5.2%
2024โ‚น43.37 B-0.2%
2023โ‚น43.46 B-32.41%
2022โ‚น64.30 B41.91%
2021โ‚น45.30 B